SCHEMBL19081669

SCHEMBL19081669

c1ccc2c(-c3c4ccccc4c(-c4ccc5cc(-c6ccc7oc8cc9oc%10ccc%11ccccc%11c%10c9cc8c7c6)ccc5c4)c4ccccc34)cccc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.36
AHR P35869 4/20 0.35
PAX8 Q06710 2/20 0.35
CYP1A1 P04798 1/20 0.35
CYP1A2 P05177 1/20 0.35
FYN P06241 1/20 0.35
MAPK3 P27361 1/20 0.35
TDP1 Q9NUW8 3/20 0.35
MAPT P10636 3/20 0.35
NPC1 O15118 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
RAB9A P51151 1/20 0.35
TP53 P04637 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
PIM1 P11309 1/20 0.35
KDM4E B2RXH2 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081439 0.96 AHR (0.37) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL19081543 0.95 AHR (0.38) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL22063098 0.95 ABCG2 (0.38) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL19081665 0.94 ABCG2 (0.35) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL19081531 0.94 AHR (0.36) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL17944544 0.93 CASP3 (0.38) AHRTDP1MAPTNPC1MEN1
SCHEMBL19081547 0.92 AHR (0.39) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL10122507 0.91 AHR (0.40) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL19081661 0.91 ABCG2 (0.36) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL19080070 0.90 ABCG2 (0.37) ABCG2AHRPAX8CYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ABCG2 4823/4885AHR 2453/4885PAX8 2336/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ABCG2 4823/4885AHR 2453/4885PAX8 2336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.